🔎 Trials Near Me

Hjem › T-celle-lymfom › Washington › Seattle

T-celle-lymfom kliniske forsøg i Seattle, WA

6 studier for T-celle-lymfom søger deltagere på steder i og omkring Seattle (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

RekruttererFase 2
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04803201

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

RekruttererFase 3
  • University of Washington Fred Hutch Cancer Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06561048

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

RekruttererFase 3
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06724237

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RekruttererFase 1/2
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT04104776

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

RekruttererFase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Alder 18 og opefter · Alle køn · Opdateret 11. maj 2026 · NCT07225985

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • Seattle Children's Hospital, Seattle
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

T-celle-lymfom forsøg i andre byer

Andre studier i Seattle

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.